The identification of a gain-of-function mutation in CACNA1C as the cause of Timothy Syndrome (TS), a rare disorder characterized by cardiac arrhythmias and syndactyly, highlighted unexpected roles for the L-type voltage-gated Ca 2+ The broad array of abnormalities within nonexcitable tissues in Timothy Syndrome (TS) patients (1), however, revealed that Ca V 1.2 controls critical, yet previously unknown, roles in multiple nonexcitable tissues. Identified as a novel cardiac arrhythmia syndrome associated with syndactyly and dysmorphic facial features (2), the TS defect was discovered to be a specific gain-of-function mutation (G406R) in CACNA1C, the gene encoding Ca V 1.2. The mutation greatly slows channel inactivation, and thereby prolongs cellular repolarization in cardiac myocytes, which provided a clear rationale for the cardiac arrhythmias. Yet how Ca V 1.2 affects nonexcitable cells, as indicated by additional phenotypes documented in TS, such as small teeth, baldness at birth, and dysmorphic facial features, is unclear. These phenotypes were not consistent with previously understood roles for Ca V 1.2. Here, we
Ca V 1.2 in mandibular development uncomplicated by effects in other tissues, we expressed Ca V 1.2 WT or Ca V 1.2 TS in a subset of craniofacial mesenchyme by breeding these mice with a Prx1-Cre transgenic mouse. Within the branchial arches, Prx1 drives Cre recombinase expression starting around E11.5 in the ventral surfaces (7), where we observed en dogenous Ca V 1.2 expression (Figure 1 , C and D). Prx1 also drives expression in limb bud mesenchyme (7) , in both chondrocytes and osteoblasts (8) , which allowed us to obtain material to test whether expression levels of Ca V 1.2 WT and Ca V 1.2 TS were comparable in tissues in which Prx1 is active. We isolated articular chondrocytes from the femur and tibia of Prx1 + -Ca V (Figure 2A ) or wild-type animals (not shown). In contrast, the tip of the mandible (lower jaw) extended anteriorly as far as, or beyond, the tip of the maxilla (upper jaw) in 6 of 7 mice in which Prx1 drove Ca V 1.2 TS expression ( Figure 2B ). In Prx1 -littermates, the maxilla ex tended beyond the mandible (3 of 3 animals), as in the wild-type animals ( Figure  2B ). The rela tively larger mandible in Prx1-Ca V Together, these data demonstrate that expression of the TS mutant Ca V 1.2, and not just overexpression of Ca V 1.2 WT , is necessary to recapitulate this TS phenotype.
Based on these results with the gain-of-function Ca V 1.2 TS , we hypothesized that Ca V 1.2 haploinsufficiency might affect mandible size in the opposite manner. Although previous examination of Ca V 1.2 +/-mice revealed no differences (compared with wild-type mice) in morphology or development (3) -and we also found that overall mouse size, weight, and tibial length were not different between the 2 genotypes -subtle extracardiac phenotypes might have been missed in that original study. Indeed, in a blinded analysis, we found that the normalized intracoronoid width was smaller in Ca V 1.2 +/lacZ mice (0.40 ± 0.00, n = 6) compared with wild-type littermate controls (0.48 ± 0.01, n = 6, P < 0.001) ( Figure 2D ). Together, these data suggest that altered Ca 2+ influx through Ca V 1.2 in a tissue-specific manner can affect craniofacial development.
Genetic and pharmacological manipulation shows that Ca V 1.2 regulates mandibular development in zebrafish. We exploited zebrafish to begin dissection of the molecular mechanisms by which Ca V 1.2 regulates craniofacial development. Among the advantages of this model system is that, due to oxygen diffusion, embryos do not require heart function until approximately 5 days post fertilization, a developmental stage significantly beyond when a functioning heart is nec-
Figure 1
CaV1.2 is expressed in developing jaw. (A-D) Whole-mount β-gal staining of CaV1.2 +/LacZ embryos. CaV1.2 is highly expressed in the developing heart around E9.5 (A). By E11.5 intense staining is present in the first (arrowhead) and second (arrow) pharyngeal arches (B-D). (E and F) β-gal staining of a coronal section through the first mandibular arch. F is a magnified section of the boxed area shown in E. essary in higher vertebrates and when key aspects of craniofacial development are complete. This is particularly relevant for Ca V 1.2, which is necessary for cardiac function in zebra fish (9) and mice (3). A previous study detected Ca V 1.2 expression in zebrafish embryos in the developing heart and pancreas at 26 hours post fertilization (hpf) by in situ hybridization (9), which we confirmed (Supplemental Figure 2 ). At 72 hpf, when jaw elements are visible by Alcian blue staining (Figure 3) , we detected Ca V 1.2 expression in the developing mandible and the ceratohyal cartilage (Supplemental Figure 2) . To determine the role of Ca V 1.2 in mandibular development, we designed a cocktail of 2 morpholinos targeting the donor and acceptor sites, respectively, for exon 4 of cacna1c (Supplemental Figure 3 ) and documented effective Ca V 1.2 knockdown by two different methods: we found >80% reduction in cacna1c mRNA at 72 hpf, and embryos at 48 hpf displayed the same abnormal cardiac phenotype (a non-beating, "silent" ventricle; see Supplemental Video 1) observed in cacna1c knockout embryos (9) . In contrast, a control morpholino affected neither cacna1c mRNA levels nor cardiac function (Supplemental Video 2). Alcian blue staining for cartilage elements at 72 hpf showed that Ca V 1.2 morpholino knockdown significantly affected overall jaw development, reducing the size of all jaw components ( Figure 3A) . We quantified the reduction by measuring mandibular area (highlighted by dotted lines), with the observer blinded to the treatment. Compared with no morpholino, the control morpholino had minimal effects on mandibular area (Figure 3, A and B) . Since overall embryo size and length were only minimally affected (Supplemental Figure 4) and mortality rates were unaffected by the control morpholino cocktail, we used the control morpholino as the comparator in subsequent experiments. The Ca V 1.2 knockdown morpholino cocktail reduced the mandibular area by 42 ± 3.8% after Ca V 1.2 knockdown (Figure 3, A and B) . We confirmed that the observed jaw defects were due to Ca V 1.2 knockdown and not to a nonspecific effect of the morpholinos because coinjection of a morpholino-insensitive rabbit cRNA encoding a Ca V 1.2 WT channel doubled the mandibular area compared with the Ca V 1.2 knockdown morpholino by itself, and restored mandible size almost to that observed in the control morpholino-treated embryos (43,536 ± 1,334 μm 2 for control morpholino rescued with Ca V 1.2 WT versus 44,530 ± 1,433 μm 2 for control morpholino alone; P = 0.72) (Figure 3 , A and C). As expected, coinjection of Ca V 1.2 WT cRNA also rescued cardiac function (64.4% of embryos had a beating heart at 48 hpf compared with 10% of embryos treated with morpholinos only; n = 180 for each, χ 2 = 554, P < 0.0001), providing additional evidence that the morpholinos were specific for cacna1c. To confirm that the reduced mandible size observed after morpholino treatment was independent of the effect upon cardiac function, we analyzed developing mandibles in the offspring of weak atrium (wea) and half-hearted (haf) double heterozygotes (wea;haf). The wea mutants lack atrial contractility and the haf mutants lack ventricular contractility (10) . Homozygous double mutants were identified at 48 hpf by a complete lack of atrial and ventricular contractility. These were segregated from the remaining embryos (with normal cardiac function) and mandible size, analyzed by Alcian blue staining at 72 hpf, was measured in both groups. As shown in Supplemental Figure 5 , the absence of cardiac activity (in the wea;haf homozygotes) did not reduce mandible size, suggesting that the specific knockdown of Ca V 1.2 by morpholinos affected mandible size independent of effects upon cardiac function.
Figure 2
We were therefore able to query the effects of rescue with informative mutants. Like Ca V 1.2 WT cRNA, coinjection of a Ca V 1.2 TS cRNA also doubled mandible size. Although Ca V 1.2 TS cRNA did not increase the mandible size more than Ca V 1.2 WT cRNA, it did affect chondrocyte size and pattern within the developing mandible of sox10 + zebrafish embryos treated with CMO or MO. *P < 0.001. Note that we were unable to use 1-phenyl 2-thiourea, the tyrosinase inhibitor commonly used to block pigmentation and aid visualization (for BrdU staining) in zebrafish because it interferes with neural crest development (32) : the larger red nuclei likely denote newly produced melanocytes, which migrate to the same area, and were not counted.
(see Figure 4F ). We next tested whether jaw development depended upon Ca 2+ influx through Ca V 1.2 with a Ca 2+ -impermeant rabbit Ca V 1.2, in which 4 key aspartate residues in the channel's poreforming α 1C subunit were mutated to glutamine. This 4EQ mutant (Ca V 1.2 4EQ ) retains its ability to scaffold other signaling proteins (e.g., auxiliary subunits) and to conduct ions, but completely blocks Ca 2+ permeation (11) . Unlike Ca V 1.2 WT or Ca V 1.2 TS , Ca V 1.2 4EQ did not restore mandible size when coinjected with the Ca V 1.2 knockdown morpholino cocktail ( Figure 3 , A and C).
Finally, we validated the morpholino knockdown effects and confirmed the requirement for Ca 2+ influx by two additional approaches. First, we measured mandible size in the offspring of heterozygotes of the Ca V 1.2 null mutant cacna1c m231 zebrafish (12) . Embryos without ventricular contraction (isl phenotype) (9) at 24 hpf were separated from the rest of the clutch (beating phenotype) and mandible size was calculated at 72 hpf. The size of mandibles from embryos with the isl phenotype was reduced by more than 50% (Supplemental Figure 6) . Second, we applied the Ca V 1.2 antagonist nisoldipine, which reduced mandible size compared with the DMSO control treatment ( Figure 3, D and E) . Together, these data suggest that Ca 2+ influx through Ca V 1.2 is necessary for regulating mandible size during development.
Ca 2+ influx through Ca V 1.2 regulates mandibular chondrocyte hypertrophy and hyperplasia. Ca V 1.2 could affect mandible size by regulating cellular hypertrophy and/or hyperplasia. To determine if Ca V 1.2 affected cell hypertrophy, we measured cell size in the developing mandible. After staining embryos at 72 hpf with Alcian blue, flatmounted images of the lateral aspect of Meckel's cartilage ( Figure  4A ) provided an unobstructed view of individual chondrocytes, which assumed a regular and linear pattern that we exploited to quantify the individual cell area ( Figure 4B ). Pharmacological blockade of Ca V 1.2 with nisoldipine reduced cell size ( Figure 4 , B and C), consistent with the effects on the mandible (see Figure 3D ) and also affected the linear organized pattern. Cell area was also reduced by Ca V 1.2 knockdown morpholinos compared with embryos injected with a control morpholino or noninjected controls. As with overall mandible size, cell size was restored by coinjection of a morpholino-insensitive Ca V 1.2 WT but not by the Ca 2+ -impermeant mutant Ca V 1.2 4EQ (Figure 4 , D-G). Interestingly, after coinjection of Ca V 1.2 TS , cell size was not only restored (and even larger than rescue with Ca V 1.2 WT ), but also this region of the Meckel's cartilage appeared to be crowded with additional cells ( Figure 4F ). This suggests that Ca 2+ influx through Ca V 1.2 might also regulate cellular hyperplasia in the developing mandible. We measured cell proliferation in developing mandibles of transgenic zebrafish embryos in which GFP is driven by the sox10 promoter, a marker of the cranial neural crest (13) . In these embryos, the developing mandible is GFP + by 72 hpf, at which point we labeled embryos (treated with control morpholino or Ca V 1.2 morpholinos) with BrdU and calculated the percentage of cells that were both GFP + and BrdU + compared with the total number of GFP + cells in the section. There was a significantly lower percentage of both BrdU + and double-labeled cells in the Ca V 1.2 morpholinotreated embryos within the mandible ( Figure 4H ). Together, these data suggest that Ca V 1.2 controls chondrocyte hypertrophy and hyperplasia during mandibular development.
Calcineurin lies downstream of Ca V 1.2 in regulating size and hypertrophy in mandibular chondrocytes. The regulation of cellular hypertrophy (Figure 4 ) suggested to us that the Ca 2+ -dependent phosphatase calcineurin, which regulates the nuclear factor of activated T cells (NFAT) signaling pathway, might be one candidate for a regulator downstream of Ca V 1.2, as this pathway regulates hypertrophy in several cell types, such as cardiac myocytes (14) . We tested this hypothesis with two independent approaches. First, we inhibited calcineurin activity with FK506 and cyclosporine with doses previously used in zebrafish (15) . Mandibular area and cell size were reduced compared with a DMSO control treatment ( Figure 5, A  and B) , reminiscent of the effects after loss of Ca 2+ influx through Ca V 1.2 (see Figures 3 and 4) . To query whether calcineurin might be downstream of Ca V 1.2, we then bypassed the requirement for Ca 2+ influx through Ca V 1.2 by coinjecting cRNA for a constitutively active, Ca 2+ -insensitive calcineurin (caCN) (16) with Ca V 1.2 morpholinos. This treatment partially restored mandible size and cell size ( Figure 5, C and D) . This second approach also helped confirm that the Ca V 1.2-dependent effects on mandibular development were independent of cardiac function, since the rescue of mandible and cell size did not correlate with the restoration of cardiac function in Ca V 1.2 morpholino-treated embryos (Supplemental Video 3). We also examined whether calcineurin affected cell size. Using analyses similar to those shown in Figure 4 , we demonstrated that calcineurin inhibition with FK506 and cyclosporine reduced cell size compared with DMSO ( Figure 5, E and F) . On the other hand, coinjection of cRNA for a constitutively active, Ca 2+ -insensitive calcineurin markedly increased cell size ( Figure 5, G and H) .
Mandibular progenitor cells express functional Ca V 1.2 channels. The identification of Ca V 1.2 expression in cranial neural crest-derived cells (Figure 1 , E and F) and the developmental effects observed after perturbing Ca V 1.2 ( Figures 2-4) , prompted us to test whether cranial neural crest cells express functional Ca V 1.2 channels. Previously, voltage-gated L-type Ca 2+ channels have been hypothesized to regulate neural crest migration and differentiation (17) , yet the contributions of specific L-type Ca 2+ channels have not been identified, and analysis by electrophysiologic methods has not yet been performed. We did not find that Ca V 1.2 regulated cranial neural crest cell migration. Using the sox10-GFP transgenic zebrafish embryos to visualize the cranial neural crest cells that migrate dorsolaterally in distinct streams from the neural tube to form craniofacial structures, we found that cranial neural crest migration was unaffected in embryos treated with Ca V 1.2 morpholinos ( Figure 6A ). The development of a grossly intact, albeit smaller, jaw in embryos treated with Ca V 1.2 morpholinos (Figure 3 ) also suggested that cranial neural crest migration does not depend upon Ca V 1.2. We queried the presence of Ca V 1.2 Ca 2+ channels in cranial neural crest cells by comparing voltage-gated Ca 2+ currents in cells isolated from morpholino-treated and wild-type embryos. We isolated single GFP + cells from decapitated heads obtained from sox10-GFP zebrafish embryos at 64 to 66 hpf ( Figure 6, A and B) . Cells without processes were chosen for electrophysiologic analysis to reduce the chance of recording from neuron precursors. The cells were small (average cell capacitance was 1.55 ± 0.3 pF). Resting membrane potential was -35.9 ± 2.7 mV, consistent with what has previously been recorded in cranial neural crest cells (18) . Using the whole-cell patch-clamp technique, a ramp protocol in the presence of 15 mM Ba 2+ elicited small inward currents in cells isolated from wild-type embryos, but never in cells isolated from embryos treated with the Ca V 1.2 morpholinos, which always displayed outward currents under these conditions ( Figure 6, C and D) .
Discussion
Although identification of CACNA1C as the TS locus revealed unexpected roles for Ca V 1.2 in nonexcitable cells (1), Ca V 1.2 participation outside of neurons, muscle, and hormone-secreting cells has received little attention. Here, we provide to the best of our knowledge the first evidence for how Ca V 1.2 participates in mandibular development and thereby contributes to the dysmorphic facial features that have been reported in more than half of TS patients. Using a combination of mouse and zebrafish models, we demonstrated that Ca 2+ influx through Ca V 1.2 is necessary for proper mandibular development.
Regulation of Ca 2+ influx is the best-characterized role for Ca V 1.2, but voltage-gated Ca 2+ channels anchor large macromolecular complexes (19) and could therefore control cellular processes independent of Ca 2+ influx. Indeed, the Ca 2+ channel auxiliary subunit β4 controls epiboly in zebrafish through a Ca 2+ -independent manner (20) . The inability of the Ca V 1.2 4EQ channel to rescue the Ca V 1.2 morpholino effects ( Figure 3 , A and C) and the smaller jaws observed after pharmacologic blockade of Ca V 1.2 with nisoldipine ( Figure 3 , D and E) provide additional evidence that mandibular development depends directly on Ca 2+ influx through Ca V 1.2. Dihydropyridines have not been shown to disrupt the Ca V 1.2 macromolecular complex, and the Ca V 1.2 4EQ channel remains a voltage-sensitive cation channel -though one that is not able to permeate Ca 2+ due to loss of the high-affinity binding site in the pore (11) . Thus, we conclude that functions other than Ca 2+ permeation are unlikely to contribute to the Ca V 1.2-dependent regulation of mandibular development.
Our hypothesis is further reinforced by the complementary effects on mandible size with gain-of-function and loss-of-function approaches in mice: Ca V 1.2 haploinsufficiency reduced mandible size, while expression of a Ca V 1.2 TS mutant channel in the developing jaw and the accompanying augmented Ca 2+ influx increased mandible size (Figure 2 ). While we observed an increase in mandible size in mice expressing Ca V 1.2 TS , the original description in TS patients reported a small upper jaw (maxilla) (1) . We suspect that the maxilla in TS patients appears relatively small in comparison with the abnormally large mandible, as shown in the x-rays from Prx1-Ca V 1.2 TS mice ( Figure 2B ). In zebrafish, the inability of Ca V 1.2 TS cRNA to increase mandible size more than Ca V 1.2 WT cRNA did likely reflects that the zebrafish model is best suited to inform about earlier developmental events. The cRNA was injected into a single-cell embryo along with cacna1c morpholinos. As the embryo increases in size and cell number, both the amount of morpholino and Ca V 1.2 TS cRNA per cell become diluted. Endogenous Ca V 1.2 expression increases (as shown in Supplemental Figure 3D) and likely dominates the phenotype. Nevertheless, that both Ca V 1.2 WT and Ca V 1.2 TS cRNA can rescue cacna1c morphants provides powerful evidence that our morpholinos are on target.
The cells expressing Ca V 1.2 that are responsible for these developmental effects likely include the early chondrocytes of the mandible. Using a Ca V 1.2 reporter mouse, we first identified Ca V 1.2 at E11.5 within the periphery of the first branchial arch, which contains cranial neural crest-derived cells (see Figure 1) . Consistent with these data, we recorded inward Ca 2+ currents from zebrafish cranial neural crest-derived (Sox10 + ) cells, but not after Ca V 1.2 morpholino knockdown ( Figure 6 ). The Prx1-Ca V 1.2 TS mouse model also suggests a role for developing chondrocytes, since the Prx1-Cre transgene is specifically active in the first pharyngeal arch (7) and in chondrocytes (8) .
The resting membrane potential (approximately -35 mV) recorded from the isolated cranial neural crest cells expressing a Ca V 1.2-dependent, inward Ca 2+ current suggests a mechanism by which the gain-of-function TS mutant channel could contribute to disease phenotypes in nonexcitable cells. At this voltage, steadystate inactivation curves for Ca V 1.2 WT and Ca V 1.2 TS channels begin to diverge, so the fraction of Ca V 1.2 TS channels inactivated would be significantly smaller than that of Ca V 1.2 WT channels (1). Thus, after Ca V 1.2 channels open to participate in the Ca 2+ waves that accompany neural crest migration (17, 21) , additional Ca 2+ likely continues to flow through Ca V 1.2 TS channels for some time, even after a return to more negative resting membrane potentials.
Knockdown of Ca V 1.2 by morpholinos resulted in a smaller jaw, but one that appeared to have all of its elements, suggesting that Ca V 1.2 exerts its effects after cranial neural crest migration. Consistent with that, we did not observe any defect in cranial neural crest migration after Ca V 1.2 knockdown ( Figure 6A ). Rather, Ca V 1.2 appears to participate in the subsequent hypertrophy and hyperplasia of the developing chondrocytes.
Calcineurin appears to be one Ca 2+ -dependent effector downstream of Ca V 1.2 based on two lines of evidence. First, inhibition of calcineurin produced a phenotype similar to pharmacological blockade of Ca 2+ influx through Ca V 1.2 or Ca V 1.2 knockdown. Second, expression of a constitutively active calcineurin was able to bypass the requirement for Ca 2+ influx through Ca V 1.2 ( Figure 6 ). It is intriguing that calcineurin is a part of the Ca V 1.2 macromolecular complex, having been shown to interact either directly with Ca V 1.2 (22) or through an A-kinase anchoring protein (23) . The most likely target of activated calcineurin is NFAT. The ability of constitutively active calcineurin to induce hypertrophy in developing chondrocytes is consistent with its well-documented roles in cardiac myocyte hypertrophy (24) . Indeed, transgenic overexpression of NFAT, either in chondrocytes/osteoblasts or osteoclasts, leads to abnormal craniofacial development (25, 26) . Since the rescue with constitutively active calcineurin was incomplete, additional Ca 2+ -sensitive pathways downstream of Ca V 1.2 are likely necessary.
The mechanisms by which Ca V 1.2 affects cellular processes in other nonexcitable tissues may be similar in some cases and different in others. For example, the baldness observed in all TS patients at birth could result from excessive activation of the calcineurin/NFAT pathway (via the mutant Ca V 1.2), as suggested by the hirsutism side effect commonly seen in patients treated with calcineurin inhibitors for immunosuppression. On the other hand, it is not readily obvious how the mutant Ca V 1.2 leads to the invariant syndactyly phenotype through a calcineurin/NFAT pathway. Interdigital apoptosis has been shown to be induced by BMPs, counterbalanced by noggin, a BMP antagonist, and survival signals from FGFs, all under the master control of the secreted morphogen Sonic hedgehog (Shh) (27) , but not from an NFAT-dependent process.
compressed by a coverslip before confocal microscopy. Quantification was performed using ImageJ software (NIH). A threshold was set and only cells containing GFP were examined for BrdU staining.
Antisense morpholino knockdown and RNA rescue analysis. Two morpholino oligonucleotides (Gene Tools) against cacna1c were designed against the splice-site acceptor of exon 4 (CCCGTTCCTAGACAGACGAAACAGA) and the splice-site donor of exon 4 (GGATCTTGCACTCACCTAC-GACCA). Two scrambled 25-nt control morpholinos were designed by Gene Tools. Morpholinos were diluted and injected at 2 ng per embryo in a 2-nl bolus into single-cell zygotes. Efficacy of knockdown was assessed by quantitative PCR (qPCR) (Supplemental Figure 3) using qRT-PCR following protocols previously described. Primers used were as follows: Exon 3 forward, TTGCAAACTGTGTGGCCTTAGCTG; Intron 3 forward, CCGGTGCAAAGACTTTCAGTGTGT; Exon 4 forward, TCACCCTAAT-GCATACCTGCGGAA; and Exon 5 reverse, TTGCCTCCCATTGAAG-TACCACCA. Rabbit Cacna1c cRNA (CaV1.2 WT ) was prepared as described previously from pCARDHE using T7 mMESSAGE mMACHINE (Ambion, Life Technologies) (30) . The CaV1.2 TS cRNA was prepared after mutating pCARDHE (G436R) with QuikChange (Agilent). The CaV1.2 4EQ cRNA was prepared after simultaneously mutating E393, E736, E1145, and E1446 to A using the QuikChange Multi Site-Directed mutagenesis kit (Agilent Technologies). The constitutively active calcineurin cDNA was provided by Paul Rosenberg (Duke University, Durham, North Carolina, USA) and cloned into pGHE for cRNA synthesis. Each construct was coinjected with the cacna1c morpholinos at 800 pg per embryo where indicated in the text.
Pharmacology and drugs. Nisoldipine, FK506, and cyclosporine were dissolved in DMSO (all from Sigma-Aldrich). Embryos (24 hpf) were chemically and manually dechorionated using pronase. Drugs were applied directly into embryo medium, which was supplemented with fresh medium every 24 hours. The following concentrations were used: 1% DMSO (vol/ vol), 5 μM nisoldipine, 5 μm cyclosporine, and 1 μm FK506.
Neural crest isolation and electrophysiology. Embryos (sox10:egfp) at 64 to 66 hpf were anesthetized with 2X tricaine and then decapitated in HBSS without calcium or magnesium. Isolated heads were washed in HBSS, manually dissected, and then cells were enzymatically dissociated with a combination of collagenase and trypsin-EDTA in HBSS. Cells were spun down, washed, and resuspended in 10% FBS, 1% penicillin/streptomycin, and DMEM-F12 and incubated on glass coverslips coated with fibronectin, poly-D-lysine, and laminin. Ba 2+ currents were recorded using the wholecell patch-clamp technique. Patch pipettes were fabricated from borosilicate glass (Warner Instruments) by a P-97 Flaming-Brown micropipette puller (Sutter Instruments). Pipette resistance was between 6.0 and 8.0 MΩ. Voltage-clamp experiments were performed with an Axopatch 200B amplifier (Molecular Devices) at room temperature (20°C-22°C) 2 hours after plating. A Tyrode bath solution contained (in mM; Sigma-Aldrich) NaCl 140, KCl 5.4, CaCl2 1, MgCl2 1, HEPES 5, and glucose 10 (pH 7.3). Once the cell was ruptured, solution was quickly exchanged to a Ba 2+ recording solution containing (in mM; Sigma-Aldrich) TEA-Cl 110, CsCl 5, BaCl2 15 mM, MgCl2 1, HEPES 5, glucose 10, and 4-aminopyridine 2, pH 7.2, with CsOH. IBa was recorded using a ramp protocol from -80 to +60 over 500 milliseconds. Internal solution contained (in mM; Sigma-Aldrich) CsOH-H2O 70, aspartic acid 80, CsCl 40, NaCl 10, HEPES 10, EGTA 10, MgATP 5, and Na2GTP 4 (pH 7.2). Recordings were filtered at 2 kHz and digitally sampled at 25 kHz. Whole-cell membrane capacitance was calculated by integrating the capacitive transient elicited by a 5-mV pulse from -80 mV to 75 mV. Pipette capacitance was corrected and whole-cell capacitance and series resistance were at least 80% compensated. Peak negative currents were normalized to cell capacitance and reported as current density (pA/pF). To record resting membrane potential, a perforated patch with Our findings provide a platform to specifically define the unexpected contributions of Ca V 1.2 to nonexcitable tissues and to explore more generally the roles of ion channels in these tissues. Loss-of-function mutations in GJA1, the gene coding for the gapjunction protein connexin43, underlie oculodentodigital dysplasia, which shares several features with TS, including craniofacial and tooth abnormalities, as well as syndactyly (28) . This study provides additional support for the concept that ion channels are critical for multiple, unexpected processes in nonexcitable tissues.
Methods
Mouse models. CaV1.2 +/LacZ mice (B6.129P2-Cacna1c tm1Dgen /J) were obtained from The Jackson Laboratory. CaV1.2 WT and CaV1.2 TS mice, previously described (6), were crossed with Prx1-Cre (B6.Cg-Tg[Prx1-cre]1Cjt/J; The Jackson Laboratory). Mandible and tibia measurements were performed at the times indicated either by dissection and isolation or by x-ray imaging on a Faxitron LX-60 Digital Radiography System acquired at a voltage of 26 kV and a 13-second acquisition time. All mouse experiments were approved by the Institutional Animal Care and Use Committee at Duke University.
Zebrafish embryo collection and preparation. Zebrafish (Danio rerio) were maintained following published protocols (29) and various developmental stages were identified as described previously. wea and haf mutants (provided by Deborah Yelon, New York University School of Medicine, New York, New York, USA) were bred to generate wea;haf double heterozygotes. Wild-type Tübingen fish; wea;haf double heterozygotes; isl (cacna1c m231 ; provided by Calum MacRae, Harvard University, Cambridge, Massachusetts, USA); and transgenic fish expressing eGFP under control of the sox10 promoter (sox10:egfp, provided by Thomas Schilling, UC Irvine, Irvine California, USA) were used to obtain embryos where indicated in the text. All zebrafish experiments were approved by the Institutional Animal Care and Use Committee of Duke University.
Whole-mount Alcian blue staining and whole-mount cell-size imaging. At 72 hpf, fish were anesthetized with 1X tricaine and fixed in 2% paraformaldehyde and PBS (wt/vol) for 2 to 4 hours. After a graded rinse in ethanol, they were transferred into a solution of 0.1% Alcian blue (Sigma-Aldrich), 80% ethanol, and 20% acetic acid (wt/vol/vol) and incubated overnight at 4°C. After a series of graded ethanol-PBS rinses, embryos were bleached with 1% KOH and 3% H2O2 (vol/vol) for 2 hours, followed by a mild digestion overnight at 4°C with 0.05% trypsin, EDTA, saturated sodium tetraborate, and PBS (vol/wt/vol). Stained embryos were preserved and imaged in 80% glycerol (vol/vol). Quantification on the whole mandible was performed with ImageJ software (NIH) with the observer blinded to the treatments. Following whole mandible imaging and quantification, embryos were decapitated and had excess tissue stripped before being flat-mounted between a slide and coverslip. Images were then taken on a Leica phasecontrast compound light microscope. Images were contrast and brightness enhanced. Data analysis was performed with OriginLab 8.5.
Immunohistochemistry. Embryos (sox10:egfp) at 76 hpf were treated with bromodeoxyuracil (BrdU) for 1 hour over ice and were allowed to recover for 1 hour at 27.8°C. Embryos were then anesthetized with 1X tricaine and fixed in 4% paraformaldehyde and PBS (wt/vol) for 2 hours. Fish were then washed gradually into 100% methanol for 3 days at 4°C. Subsequently, they were rehydrated into PBS, treated with 2N HCl at 42°C for 30 minutes. Statistics. Differences in measured variables between genetically altered mice and the control group or between or among treatment groups were assessed using a 2-tailed Student's t test, ANOVA, or χ-squared test, where appropriate. Data are expressed as mean ± SEM where applicable. A P value less than 0.05 was considered a statistically significant difference.
Study approval. All animal studies were approved by the Institutional Animal Care and Use Committee of Duke University.
